Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277343
Max Phase: Preclinical
Molecular Formula: C19H23NO3
Molecular Weight: 313.40
Associated Items:
ID: ALA5277343
Max Phase: Preclinical
Molecular Formula: C19H23NO3
Molecular Weight: 313.40
Associated Items:
Canonical SMILES: Cc1cc(=O)c(O)c(CN2CCC(Cc3ccccc3)CC2)o1
Standard InChI: InChI=1S/C19H23NO3/c1-14-11-17(21)19(22)18(23-14)13-20-9-7-16(8-10-20)12-15-5-3-2-4-6-15/h2-6,11,16,22H,7-10,12-13H2,1H3
Standard InChI Key: GMLIDJVAUOVLEC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 313.40 | Molecular Weight (Monoisotopic): 313.1678 | AlogP: 3.11 | #Rotatable Bonds: 4 |
Polar Surface Area: 53.68 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.44 | CX Basic pKa: 7.26 | CX LogP: 3.13 | CX LogD: 2.87 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.94 | Np Likeness Score: -0.08 |
1. He M, Fan M, Peng Z, Wang G.. (2021) An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery., 221 [PMID:34023737] [10.1016/j.ejmech.2021.113546] |
Source(1):